Gast ::
| Hauptseite > Publikationsdatenbank > Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group |
| Hauptseite > Publikationsdatenbank > Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group |
| Journal Article | FZJ-2021-01076 |
; ; ; ; ; ; ; ; ; ; ; ; ;
2021
Oxford Univ. Press
Oxford
This record in other databases: 
Please use a persistent id in citations: http://hdl.handle.net/2128/27922 doi:10.1093/neuonc/noab013
Abstract: The management of patients with glioma usually requires multimodality treatment including surgery, radiotherapy, and systemic therapy. Accurate neuroimaging plays a central role for radiotherapy planning and follow-up after radiotherapy completion. In order to maximize the radiation dose to the tumor and to minimize toxic effects on the surrounding brain parenchyma, reliable identification of tumor extent and target volume delineation is crucial. The use of positron emission tomography (PET) for radiotherapy planning and monitoring in gliomas has gained considerable interest over the last several years, but Class I data are not yet available. Furthermore, PET has been used after radiotherapy for response assessment and to distinguish tumor progression from pseudoprogression or radiation necrosis. Here, the Response Assessment in Neuro-Oncology (RANO) working group provides a summary of the literature and recommendations for the use of PET imaging for radiotherapy of patients with glioma based on published studies, constituting levels 1-3 evidence according to the Oxford Centre for Evidence-based Medicine.
; 
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz
; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF
Fulltext by OpenAccess repository